Related Experiment Videos
CD54 expression is predictive for lymphatic spread in human gastric carcinoma
Masakazu Yashiro1, Takeshi Sunami, Kosei Hirakawa
1The Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan m9312510@med.osaka-cu.ac.jp
Digestive Diseases and Sciences
|January 18, 2006
Summary
CD54 expression on gastric cancer cells predicts lymph node metastasis and patient prognosis. Lower CD54 levels correlate with more extensive lymph node involvement and poorer outcomes in gastric carcinoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Gastric carcinoma exhibits variable lymph node metastasis despite similar lymphatic invasion.
- Additional factors may influence lymphangitic spread in gastric cancer.
Purpose of the Study:
- To investigate the correlation between CD54 expression in gastric cancer cells and clinicopathologic features.
- To determine if CD54 expression predicts lymphatic spread and prognosis in gastric carcinoma.
Main Methods:
- Analysis of primary gastric tumors from 78 patients with similar pathologic lymphatic invasion.
- Assessment of CD54 expression on cancer cells.
- Correlation of CD54 expression with the number and extent of lymph node involvement and patient prognosis.
Main Results:
- Decreased CD54 expression was significantly associated with increased lymph node involvement and spread.
- Patients with CD54-negative tumors had a significantly worse prognosis compared to CD54-positive tumors.
- CD54 expression levels correlated with the number of diseased lymph nodes.
Conclusions:
- CD54 expression on cancer cells is a significant predictor of lymphatic metastasis in gastric carcinoma.
- CD54 expression serves as a prognostic marker for gastric carcinoma patients.
- Targeting CD54 may offer therapeutic strategies for improving outcomes in gastric cancer.